AI assistant
SYNLOGIC, INC. — Director's Dealing 2015
Oct 1, 2015
35028_dirs_2015-09-30_a2fd4a18-0b74-45c5-b010-bedb768e2dd1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Mirna Therapeutics, Inc. (MIRN)
CIK: 0001527599
Period of Report: 2015-09-30
Reporting Person: PFIZER INC (10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series C Convertible Preferred Stock | $ | Common Stock (1047806.0000) | Direct | ||
| Series D Convertible Preferred Stock | $ | Common Stock (491418.0000) | Direct |
Footnotes
F1: The Series C Convertible Preferred Stock is convertible into Common Stock at any time at the option of the holder. The Series C Convertible Preferred Stock will automatically convert into Common Stock on a 1-to-1 basis upon closing of the initial public offering of the issuer.
F2: Not Applicable.
F3: The Series D Convertible Preferred Stock is convertible into Common Stock at any time at the option of the holder. The Series D Convertible Preferred Stock will automatically convert into Common Stock on a 1-to-1 basis upon closing of the initial public offering of the issuer.